New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
14:48 EDTMUR, MDCO, SNSS, EWP, TCHigh option volume stocks: TC SNSS MUR EWP MDCO
News For TC;SNSS;MUR;EWP;MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 15, 2014
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTSNSSSunesis upgraded at Roth Capital
Subscribe for More Information
08:55 EDTMURMurphy Oil coverage resumed with a Neutral at Goldman
Subscribe for More Information
06:06 EDTSNSSSunesis upgraded to Buy from Neutral at Roth Capital
Subscribe for More Information
December 11, 2014
10:13 EDTTCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARIAD (ARIA) downgraded at Credit Suisse... AbbVie (ABBV) downgraded to Equal Weight from Overweight at Morgan Stanley... Aimco (AIV) downgraded to Hold from Buy at KeyBanc... Anglo American (AAUKY) downgraded to Underperform from Neutral at Exane BNP Paribas... Approach Resources (AREX) downgraded at Sterne Agee... CommVault (CVLT) downgraded to Neutral from Outperform at Macquarie... Fifth Street Senior (FSFR) downgraded to Perform from Outperform at Oppenheimer... Harmonic (HLIT) downgraded to Neutral from Buy at Sidoti... Macerich (MAC) downgraded to Hold from Buy at Deutsche Bank... Newell Rubbermaid (NWL) downgraded to Outperform from Strong Buy at Raymond James... Olin Corp. (OLN) downgraded at Longbow... Penn West (PWE) downgraded to Underperform from Neutral at BofA/Merrill... Prudential plc (PUK) downgraded to Neutral from Buy at Nomura... Semiconductor Manufacturing (SMI) downgraded to Hold from Buy at Jefferies... Suncor (SU) downgraded to Neutral from Buy at BofA/Merrill... Talisman Energy (TLM) downgraded to Underperform from Neutral at BofA/Merrill... Thompson Creek (TC) downgraded to Hold from Buy at Deutsche Bank... Toll Brothers (TOL) downgraded to Underperform from Sector Perform at RBC Capital... Travelers (TRV) downgraded to Neutral from Buy at UBS... United Therapeutics (UTHR) downgraded at Credit Suisse... Vera Bradley (VRA) downgraded to Underperform from Neutral at Sterne Agee.
08:02 EDTMDCOAlnylam, The Medicines Co. announce initiation of Phase 1 ALN-PCSsc trial
Subscribe for More Information
06:28 EDTTCThompson Creek downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
December 10, 2014
15:05 EDTTCThompson Creek to place Endako molybdenum mine on temporary suspension
Thompson Creek Metals announced that it and its joint venture partner, Sojitz Moly Resources, have agreed to place the Endako molybdenum mine on temporary suspension effective December 31, due to continued weakness in the molybdenum market. Thompson Creek holds a 75% interest in the Endako Mine, and Sojitz holds the remaining 25% interest. Approximately 50% of salaried employees at the Endako Mine will be terminated, resulting in estimated severance costs of approximately C$1.7M. Hourly employees at the Mine were notified today that their employment will be temporarily suspended in sixty days, and will remain so suspended while the Mine is on temporary suspension.
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTSNSSOn The Fly: Pre-market Movers
Subscribe for More Information
06:40 EDTSNSSSunesis upgraded to Buy from Hold at Cantor
Subscribe for More Information
December 8, 2014
19:03 EDTTCThompson Creek COO Scott Shellhaas to leave company
Thompson Creek Metals Company announced that Scott Shellhaas, the company's president and COO, is leaving the company effective December 12. Thompson Creek's board has appointed Jacques Perron as president effective immediately in addition to his continued role as CEO and director. As the company prepares to place the Thompson Creek molybdenum mine into care and maintenance at year-end, it has streamlined the management of its operations and eliminated the position of COO.
13:34 EDTSNSSSunesis announces positive results from ongoing trial of Vosaroxin
Subscribe for More Information
12:40 EDTSNSSOn The Fly: Midday Wrap
Subscribe for More Information
12:25 EDTMDCOAntibiotic makers rise after Merck agrees to buy Cubist
Subscribe for More Information
10:11 EDTMDCOHigh option volume stocks
Subscribe for More Information
09:29 EDTSNSSSunesis risk/reward attractive, says RBC Capital
RBC Capital believes that the EU could approve Sunesis' vosaroxin drug. The firm says that an EU approval would lift the stock by about 35%, and ir keeps a $3 price target and Sector Perform rating on the shares.
05:51 EDTSNSSSunesis to host conference call
Conference call to discuss results from the Phase 3 VALOR trial of vosaroxin and cytarabine will be held on December 9 at 1:30 pm. Webcast Link
December 7, 2014
16:42 EDTSNSSSunesis announces presentation of Phase 3 VALOR trial results
Subscribe for More Information
December 6, 2014
09:15 EDTSNSSSunesis to hold a meeting
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use